86698312 - VECTURA

Information

• Trademark
• 86698312

• Source

• Serial Number

  86698312

• Registration Number

  5174039

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 20, 2015
  9 years ago

• Registration Date

  April 04, 2017
  7 years ago

• Transaction Date

  November 28, 2023
  12 months ago

• Status Date

  October 20, 2023
  a year ago

• Published for Opposition Date

  January 17, 2017
  7 years ago

• Location Date

  April 04, 2017
  7 years ago

• Status Code

  710

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  JOHNSON, DANYTHE ELIZA

• Attorney Docket Number

  38618-388698

  Attorney Name

  Mark Harrison

  Law Office Assigned Location Code

  N20

• Owners

  • Vectura GmbH

Case File Statements

• GS0051: Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma; all of the above goods not for use in the dental field
• GS0101: Surgical, medical, and veterinary apparatus, instruments and parts and fittings therefor, namely, drug delivery devices and parts and fittings therefor, namely, drug delivery systems; inhalers for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapy, namely, respiration therapy, and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; dispensing devices for the metering and dispensing of orally ingestible drugs for medical or therapeutic purposes and parts and fittings therefor, namely, medical apparatus and units for dosage and measuring, namely, drug delivery devices and systems; aerosol dispensers for medical or therapeutic purposes and parts and fittings therefor; all of the above goods not for use in the dental field
• GS0421: Scientific research and technological services, namely, research, design, analysis, and testing, in the field of pharmaceuticals and drug delivery systems, and drug delivery systems and devices; Scientific research and technological services, namely, research in the field of medicine; industrial analysis and research services in the fields of drug delivery systems and devices; research services in the fields of medicine; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services; preparation and formulation of pharmaceuticals, namely, consulting services in the field of pharmaceutical formulation, development of medical applications for drugs and pharmaceutical formulations, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations

Case File Event Statements

• 10/20/2023 - a year ago

  26 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 4/4/2022 - 2 years ago

  25 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 4/4/2017 - 7 years ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/17/2017 - 7 years ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/17/2017 - 7 years ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/28/2016 - 7 years ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/12/2016 - 7 years ago

  20 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/28/2016 - 7 years ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/17/2016 - 8 years ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/17/2016 - 8 years ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/17/2016 - 8 years ago

  16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/25/2016 - 8 years ago

  15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/25/2016 - 8 years ago

  14 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/25/2016 - 8 years ago

  13 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/4/2016 - 8 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/4/2016 - 8 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/2/2016 - 8 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/5/2015 - 9 years ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/5/2015 - 9 years ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/5/2015 - 9 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/29/2015 - 9 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 10/19/2015 - 9 years ago

  5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 10/9/2015 - 9 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 9/21/2015 - 9 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 7/24/2015 - 9 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/23/2015 - 9 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP